Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
47.03
-4.17 (-8.14%)
Dec 27, 2024, 4:00 PM EST - Market closed
Tectonic Therapeutic Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -53.48 | -42.82 | -32.18 | -8.93 |
| Depreciation & Amortization | 1.51 | 1.48 | 1.01 | 0.36 |
| Other Amortization | - | - | - | 0.25 |
| Loss (Gain) From Sale of Assets | 0.01 | 0.01 | - | - |
| Stock-Based Compensation | 2.67 | 1.12 | 1.12 | 0.64 |
| Other Operating Activities | 3.8 | 0.12 | 0.58 | -6.7 |
| Change in Accounts Payable | -4.17 | -0.17 | -1.23 | 1.45 |
| Change in Other Net Operating Assets | -4.26 | -0.42 | 3.07 | 0.46 |
| Operating Cash Flow | -53.92 | -40.68 | -27.64 | -12.45 |
| Capital Expenditures | -0.2 | -0.28 | -2.09 | -2.12 |
| Investing Cash Flow | -0.2 | -0.28 | -2.09 | -2.12 |
| Long-Term Debt Issued | - | - | - | 4 |
| Long-Term Debt Repaid | - | -0.5 | -0.39 | -0.39 |
| Net Debt Issued (Repaid) | -0.48 | -0.5 | -0.39 | 3.61 |
| Issuance of Common Stock | 131.57 | 34.25 | 0 | 0 |
| Financing Cash Flow | 206.91 | 33.75 | 37.63 | 41.42 |
| Foreign Exchange Rate Adjustments | -0.03 | 0.02 | - | - |
| Net Cash Flow | 152.77 | -7.2 | 7.9 | 26.84 |
| Free Cash Flow | -54.12 | -40.96 | -29.73 | -14.58 |
| Free Cash Flow Per Share | -3.67 | -15.55 | -11.77 | - |
| Levered Free Cash Flow | -26.79 | 5.96 | -18.46 | - |
| Unlevered Free Cash Flow | -26.71 | 6.05 | -18.37 | - |
| Change in Net Working Capital | -2.69 | -31.64 | -2.11 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.